LVMH

기술 요약

지표	수치	추세

지표	수치	추세

지표	수치	추세

지표	S3	S2	S1	P	R1	R2	R3

뉴스

Reuters - 4 시간 전

JPM trims estimates, PT ahead of LVMH's Q3 on China softness

BUZZ-JPM trims estimates, PT ahead of LVMH's Q3 on China softness ** Ahead of luxury giant's LVMH LVMH.PA Q3 trading update , J.P.Morgan cuts its sales estimates citing ongoing slowdown among Chinese consumers ** JPM trims LVMH group sales growth, excluding forex , to 1.5% from 3.3% and now sees growth of 1% for its Fashion & Leather Goods business

Reuters - 5 시간 전

Unipol sees BPER, Pop Sondrio merger as "mistake", no plans to raise stakes

Unipol sees BPER, Pop Sondrio merger as "mistake", no plans to raise stakes BARCELONA, Sept 17 (Reuters) - Unipol UNPI.MI , the main shareholder in banks BPER EMII.MI and Popolare di Sondrio BPSI.MI , has no plans to raise its holding in either bank and would consider a merger between the two "a mistake", Chairman Carlo Cimbri said. Speaking to reporters on the sidelines of the Louis Vuitton Cup in Barcelona, Cimbri opened up to the idea of buying a limited stake in Monte dei Paschi BMPS.MI if t

Reuters - 6 시간 전

Auction Technology, Compass, D'Ieteren Group

EUROPE RESEARCH ROUNDUP-Auction Technology, Compass, D'Ieteren Group Sept 17 (Reuters) - Securities analysts revised their ratings and price targets on several European companies including Auction Technology, Compass Group and D'Ieteren Group on Tuesday. HIGHLIGHTS * Auction Technology Group Plc ATG.L : JP Morgan raises to overweight from neutral * Compass Group CPG.L : RBC cuts to sector perform from outperform * D'Ieteren Group SA IETB.BR : Jefferies cuts to hold from buy * Hermes HRMS.PA : Ex

Reuters - 5 일 전

Barclays weighs in on potential tariff risk for Europe if Trump wins

BUZZ-Barclays weighs in on potential tariff risk for Europe if Trump wins ** Barclays sees an up to high single-digit percent hit on European earnings if Donald Trump wins the U.S. presidential race and in the event of a full-blown trade war ** "A Trump win may raise concerns of a full-blown trade war," the British bank's strategists say in a note ** While the direct impact to potential U.S.

Reuters - 6 일 전

Novo Nordisk experimental obesity pill has mild-to-moderate side effects in trial

UPDATE 2-Novo Nordisk experimental obesity pill has mild-to-moderate side effects in trial Amycretin showed 13.1% weight loss in Phase I trial Side-effects similar to other incretin-based treatments Decision on Phase III trial pending study data next year Adds shares in paragraph 4, detail on production in paragraphs 16-17 By Jacob Gronholt-Pedersen and Maggie Fick COPENHAGEN, Sept 11 (Reuters) - Novo Nordisk NOVOb.CO said on Wednesday its highly anticipated experimental weight-loss pill amycret